The prevalence of SARS-CoV-2 antibodies in quarantine workers and high-risk communities in Vietnam

被引:3
|
作者
Hasan, Tasnim [1 ,2 ]
Thach, Pham Ngoc [3 ]
Anh, Nguyen Thu [2 ]
Hien, Le Thi Thu [2 ]
An, Nguyen Thi Mai [4 ]
Thuy, Dang Thi [3 ]
Duyet, Le Van
Dung, Nguyen Thi [5 ]
Diep, Tran Thi [5 ]
Huynh, Hoang Van
Toelle, Brett G. [1 ,2 ,6 ]
Marks, Guy B. [2 ,7 ]
Fox, Greg J. [1 ,2 ,8 ]
机构
[1] Univ Sydney, Fac Med & Hlth, Sydney, NSW 2006, Australia
[2] Woolcock Inst Med Res, Glebe, NSW 2037, Australia
[3] Natl Hosp Trop Dis, Hanoi, Vietnam
[4] Minist Hlth, Dept Planning & Finance, Hanoi, Vietnam
[5] Quang Ninh Ctr Dis Control, Quang Ninh, Vietnam
[6] Sydney Local Hlth Dist, Sydney, NSW, Australia
[7] Univ New South Wales, South Western Sydney Clin Sch, Liverpool, NSW, Australia
[8] Univ Sydney, Fac Pharm, Room 5216,Level 2,Med Fdn Bldg,K26,92-94 Parramatt, Sydney, NSW 2006, Australia
来源
IJID REGIONS | 2022年 / 2卷
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.ijregi.2021.12.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: The aim of this study was to determine the seroprevalence of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) antibodies in high-risk communities and quarantine workers in Vietnam.Methods: The prevalence of SARS-CoV-2 antibodies was measured in household contacts, close contacts, community members, and migrant workers from two sub-communes in which COVID-19 outbreaks occurred in early 2021: Bac Ma 1 and Tien. The prevalence of SARS-CoV-2 antibodies was also evaluated among quarantine workers at two facilities responsible for quarantining of contacts of COVID-19 cases.Results: Among 2069 participants from the two sub-communes, six individuals (0.3%) had detectable SARS-CoV-2 antibodies despite no history of COVID-19. This included one Vietnamese migrant worker, two community members, two household contacts, and one close contact of known COVID-19 cases. Among 50 workers at two COVID-19 quarantine facilities, including 15 health care workers (HCWs), one of the HCWs tested positive for SARS-CoV-2 antibodies (1/50, 2.0%) despite no known disease.Conclusion: The prevalence of SARS-CoV-2 antibodies was low in Vietnamese 'hotspots', suggesting limited community transmission.
引用
收藏
页码:137 / 140
页数:4
相关论文
共 50 条
  • [21] Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients
    Arteaga-Mueller, Giovanna Yazmin
    Olivo-Gutierrez, Mara
    Favela-Aragon, Karla Lizbeth
    Hernandez-Castillo, Paola Alejandra
    Esquivel-Gomez, Victor
    Camacho-Ortiz, Adrian
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (02) : 457 - 458
  • [22] Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon
    Bahlawan, Omar
    Badra, Rebecca
    Semaan, Hanna
    Fayad, Nancy
    Kamel, Mina Nabil
    El Taweel, Ahmed N.
    Gomaa, Mokhtar R.
    Sirawan, Abeer
    Berry, Atika
    Mokhbat, Jacques
    Goldstein, Jimi
    Abdallah, Jad
    Kayali, Ghazi
    ARCHIVES OF VIROLOGY, 2022, 167 (07) : 1509 - 1519
  • [23] Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients
    Giovanna Yazmin Arteaga-Müller
    Mara Olivo-Gutierrez
    Karla Lizbeth Favela-Aragon
    Paola Alejandra Hernández-Castillo
    Victor Esquivel-Gomez
    Adrian Camacho-Ortiz
    International Urology and Nephrology, 2022, 54 : 457 - 458
  • [24] Prevalence of antibodies and SARS-CoV-2 vaccination in Mexico 2022
    Carnalla, Martha
    Basto-Abreu, Ana
    Stern, Dalia
    Arantxa Colchero, M.
    Bautista-Arredondo, Sergio
    Alpuche-Aranda, Celia M.
    Martinez-Barnetche, Jesus
    Romero-Martinez, Martin
    Cortes-Alcala, Ricardo
    Lopez-Martinez, Irma
    Aparicio-Antonio, Rodrigo
    Barrientos-Gutierrez, Tonatiuh
    SALUD PUBLICA DE MEXICO, 2023, 65 : S135 - S145
  • [25] Estimating the risk of incident SARS-CoV-2 infection among healthcare workers in quarantine hospitals: the Egyptian example
    Jijon, Sofia
    Al Shafie, Ahmad
    Hassan, Essam
    Duval, Audrey
    Hamzi, Kenza
    Hendrickx, Niels
    Oodally, Ajmal
    Opatowski, Lulla
    Shirreff, George
    Smith, David R. M.
    Tamandjou, Cynthia
    Temime, Laura
    Jean, Kevin
    El-Kassas, Mohamed
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [26] Estimating the risk of incident SARS-CoV-2 infection among healthcare workers in quarantine hospitals: the Egyptian example
    Sofía Jijón
    Ahmad Al Shafie
    Essam Hassan
    Laura Temime
    Kévin Jean
    Mohamed El-Kassas
    Scientific Reports, 12
  • [27] High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2
    Menezes, Ana M. B.
    Victora, Cesar G.
    Hartwig, Fernando P.
    Silveira, Mariangela F.
    Horta, Bernardo L.
    Barros, Aluisio J. D.
    Mesenburg, Marilia A.
    Wehrmeister, Fernando C.
    Pellanda, Lucia C.
    Dellagostin, Odir A.
    Struchiner, Claudio J.
    Burattini, Marcelo N.
    Barros, Fernando C.
    Hallal, Pedro C.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [28] High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2
    Ana M. B. Menezes
    Cesar G. Victora
    Fernando P. Hartwig
    Mariângela F. Silveira
    Bernardo L. Horta
    Aluísio J. D. Barros
    Marilia A. Mesenburg
    Fernando C. Wehrmeister
    Lúcia C. Pellanda
    Odir A. Dellagostin
    Cláudio J. Struchiner
    Marcelo N. Burattini
    Fernando C. Barros
    Pedro C. Hallal
    Scientific Reports, 11
  • [29] Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
    Kohler, Philipp P.
    Kahlert, Christian R.
    Sumer, Johannes
    Flury, Domenica
    Gusewell, Sabine
    Leal-Neto, Onicio B.
    Notter, Julia
    Albrich, Werner C.
    Babouee Flury, Baharak
    McGeer, Allison
    Kuster, Stefan
    Risch, Lorenz
    Schlegel, Matthias
    Vernazza, Pietro
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (05): : 604 - 608
  • [30] Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight
    Goldblatt, D.
    Johnson, M.
    Falup-Pecurariu, O.
    Ivaskeviciene, I.
    Spoulou, V
    Tamm, E.
    Wagner, M.
    Zar, H. J.
    Bleotu, L.
    Ivaskevicius, R.
    Papadatou, I
    Jogi, P.
    Lischka, J.
    Franckling-Smith, Z.
    Isarova, D.
    Grandjean, L.
    Zavadska, D.
    JOURNAL OF HOSPITAL INFECTION, 2021, 110 : 60 - 66